Table 3 Best radiological response per protocol arm
Best radiological responses | Letrozole, n = 25 | Letrozole/bevacizumab, n = 49 | ||
|---|---|---|---|---|
n (%) | 95% CI†| n (%) | 95% CI†| |
Complete response (%) (no evidence of residual tumor) | 1 (4) | 0.1%, 20.4% | 5 (10) | 3.4%, 22.2% |
Partial response | 16 (64) | 42.5%, 82.0% | 34 (69) | 54.6%, 81.7% |
Objective response rate | 17 (68) | 46.5%, 85.1% | 39 (79) | 65.7%, 89.8% |
Stable disease | 7 (28) | 12.1%, 49.4% | 10 (21) | 10.2%, 34.3% |
Progressive disease | 1 (4) | 0.1%, 20.4% | 0 (0) | 0, 7.3% |
Mean tumor maximum diameter change | − 39% | − 26.4, − 52.2 | − 51% | − 43.5, − 58.6 |